Cresco Labs Inc. (CRLBF) stock
CRLBFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.58−0.02 (-3.13%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Cresco Labs free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was $37.75M, down 66.6% from the year before. The highest annual figure on record is $112.99M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.75M | -66.6% |
| FY2024 | Dec 31, 2024 | $112.99M | +3454.2% |
| FY2023 | Dec 31, 2023 | $3.18M | – |
| FY2022 | Dec 31, 2022 | -$64.29M | – |
| FY2021 | Dec 31, 2021 | -$79.39M | – |
| FY2020 | Dec 31, 2020 | -$95.00M | – |
| FY2019 | Dec 31, 2019 | -$116.86M | – |
See a number that looks wrong?